Immunotherapy Collaborative of Oncology Networked Communities (IC-ONC) TeleECHO Session – irAES

Immunotherapy Collaborative of Oncology Networked Communities (IC-ONC) TeleECHO Session – irAES is organized by Med Learning Group.

Released on: February 14, 2020
Expires on: February 14, 2021

Accreditation:
Credit Designation Statement:
Med Learning Group designates this web-based activity for a maximum of 1.0 AMA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the web-based activity.

Nursing Credit Information:
Purpose: This program would be beneficial for nurses involved in the care of patients with cancer who are treated or eligible for treatment with immunotherapy.
Credits: 1.0 ANCC Contact Hour(s)

Pharmacists:
Credit Designation Statement - Amedco LLC designates this activity for a maximum of 1.0 knowledge-based contact hours for pharmacists/technicians. Learners should claim only the credit commensurate with the extent of their participation in the activity.

Accreditation Statement:
Ultimate Medical Academy/CCM is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation. Awarded 1.0 contact hour(s) of continuing nursing education of RNs and APNs.

Program Overview:
This case-based enduring activity will cover the diagnosis, treatment, and management of patients with cancer who are treated or eligible for treatment with immunotherapy.

Learning Objectives:
Upon completion of the program, attendees should be able to:
• Examine clinical evidence supporting the use of immune checkpoint inhibitors both as monotherapy and combination with chemotherapy or other immune agents
• Recognize and manage immune-related adverse events (irAEs) associated with the use of checkpoint inhibitors
• Explain patient-centered SDM approaches aimed at optimizing cancer care and survivorship and the roles of the multidisciplinary team members in diagnosing and managing irAEs